Triptorelin in the management of prostate cancer

By Ploussard Guillaume   Mongiat-Artus Pierre  

Future Oncology, Vol. 9, Iss. 1, 2013-01 ,pp. : 93-102

Future Medicine

Access to resources Recommend Favorite

A Randomised Double-blind Placebo Controlled Clinical Trial Assessing the Tolerability and Efficacy of Glutathione as an Adjuvant to Escalating Doses of Cisplatin in the Treatment of Advanced Ovarian Cancer

By Parnis F.X.   Coleman R.E.   Harper P.G.   Pickering D.   Topham C.   Whittington J.R.   Tedeschi M.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1721-1721

Elsevier

Access to resources Recommend Favorite

Efficacy of a synthetic lytic peptide in the treatment of prostate cancer

By Arlotti J.A.   Cimino T.S.   Nguyen T.-S.   Dhir R.   Thomas A.   Jaynes J.M.   Caldwell A.L.   Getzenberg R.H.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 3, 2001-05 ,pp. : 97-102

Elsevier

Access to resources Recommend Favorite

Salvage treatment in prostate cancer: a clinical approach

By Bjerklund Johansen Truls E   Witzsch Ulrich   Greene Damian  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 5, 2013-05 ,pp. : 613-623

Informa Healthcare

Access to resources Recommend Favorite

A long-term study of the efficacy of treatment of localized prostate cancer1

By Friedrichs P.A.   Moul J.W.   Wojcik B.   Donatucci C.   Optenberg S.   Kreder K.   Thompson I.M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 3, Iss. 5, 1997-09 ,pp. : 171-176

Elsevier

Access to resources Recommend Favorite